Lamivudine 100 mg, 150 mg, 300 mg Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 100 mg, 150 mg, 300 mg
Reference Brands: Epivir®, Epivir-HBV® (US & EU)
Category: Hepatitis
Lamivudine Tablets are oral antiviral medications used to manage chronic Hepatitis B infection. As a nucleoside reverse transcriptase inhibitor (NRTI), Lamivudine reduces viral replication and liver inflammation. Commonly available in 100 mg strength for Hepatitis B treatment, it is approved by regulatory authorities in the EU and US. Suitable for inclusion in pharma B2B supply chains, Lamivudine is trusted for its safety, efficacy, and global therapeutic relevance.
Product Description:
Lamivudine Tablets are antiviral medications primarily used to treat chronic Hepatitis B virus (HBV) infection and HIV-1 as part of combination therapy. As a nucleoside reverse transcriptase inhibitor (NRTI), Lamivudine effectively suppresses viral replication, reducing liver inflammation and disease progression. Available in 100 mg tablets for hepatitis B and 150–300 mg for HIV, it is widely prescribed and globally trusted. Manufactured under stringent EU-GMP and USFDA standards, Lamivudine is an essential product in hospital procurement and pharma B2B export portfolios. Its proven safety, cost-effectiveness, and global demand make it a key antiviral in the EU and US healthcare markets.
Lamivudine — third party manufacturing & bulk supply
Lamivudine 100 mg, 150 mg, 300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Lamivudine is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Lamivudine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Lamivudine →Frequently Asked Questions
Lamivudine is used to treat HIV-1 infection and chronic hepatitis B. It helps decrease viral load, improve immune function, and slow disease progression when used as part of combination antiviral therapy.
Lamivudine is made from the active nucleoside reverse transcriptase inhibitor (NRTI) compound lamivudine, a synthetic analogue of cytidine.
The well-known trade names include Epivir for HIV treatment and Epivir-HBV for hepatitis B.
Epivir and Epivir-HBV are manufactured by GlaxoSmithKline (GSK) and ViiV Healthcare. Many generic manufacturers worldwide also produce lamivudine.
The generic name is lamivudine.
Common brand names include Epivir and Epivir-HBV.
Lamivudine is manufactured in various approved pharmaceutical facilities worldwide, including the UK, USA, and multiple countries in Europe and Asia, depending on the company and market.
Related Products
Human Hepatitis B Immunoglobulin (Hbig)
Strength:
100 IU or 500 IU per vial/ampoule
Form: Injection
Reference Brands: HepaGam B®, Nabi-HB®, HyperHEP B®(US); Hepatect CP, Zutectra®, HBIG Bayer®, Beriglobin® P(EU)
View Details
Diptheria Pertussis Tetanus (Dpt)Vaccine
Strength:
Diph. toxoid: ≥ 30 International Units ; Tetanus toxoid: ≥ 40 International Units
Form: Injection
Reference Brands: Daptacel®, Infanrix®(US); Boostrix® ,Tripedia® (EU)
View Details
Tenofovir Disoproxil Fumarate(Tdf) Tablets
Strength:
300 mg
Form: Oral tablets
Reference Brands: Viread (EU & US), Truvada (India)
View Details
Tenofovir Alafenamide (Taf)
Strength:
25 mg TAF per tablet
Form: Tablet
Reference Brands: Vemlidy (EU & US), Genvoya (India)
View Details
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
